Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
– PDE9 inhibitor, CRD-740, demonstrated favorable safety profile and achieved statistical significance for the trial’s primary endpoint, median increase in plasma... Read more.
EXAI Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Exscientia plc
SAN DIEGO–(BUSINESS WIRE)–$EXAI #EXAI—Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities... Read more.
AKRO Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Akero Therapeutics, Inc.
SAN DIEGO–(BUSINESS WIRE)–$AKRO #AKRO—Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities... Read more.
MBUU Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Malibu Boats, Inc.
SAN DIEGO–(BUSINESS WIRE)–$MBUU #IPO—Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities... Read more.
Altimmune, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Altimmune, Inc. (ALT) Class Action
SAN DIEGO–(BUSINESS WIRE)–$ALT #ALT—Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities... Read more.
AXT, Inc. (AXTI) Investor Notice: Robbins LLP Reminds Stockholders of the AXT, Inc. (AXTI) Class Action
SAN DIEGO–(BUSINESS WIRE)–$AXTI #AXT—Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities... Read more.
Pembina Pipeline Corporation Reports Voting Results from 2024 Annual Meeting of Shareholders
CALGARY, Alberta–(BUSINESS WIRE)–Pembina Pipeline Corporation (“Pembina” or the “Company”) (TSX: PPL; NYSE: PBA) reported the... Read more.
AIXI LOSS ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Xiao-I Corporation Investors to Inquire About Securities Class Action Investigation – AIXI
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf... Read more.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on May 10, 2024, the Compensation Committee of Mirum’s... Read more.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on May 10, 2024, the Compensation Committee of Mirum’s... Read more.